Professor
Leiden University Medical Center
Henk-Jan Guchelaar studied Pharmacy at the University of Groningen, The Netherlands and specialized as a hospital pharmacist and clinical pharmacologist. Since 2003, he is employed as a clinical pharmacist and clinical pharmacologist and professor of clinical pharmacy and chair of the department of Clinical Pharmacy & Toxicology at Leiden University Medical Center. Since october 2008, he is also appointed professor of Clinical Pharmacy at the Faculty of Science, Leiden Academic Center for Drug Research, University Leiden and chair of the Leiden University focus area ‘Translational Drug Discovery and Development’. Pharmaceutical patient care in oncology is his main area of clinical interest. He is program leader of the research program ‘Personalized Therapeutics’ investigating interindividual variability of drug response. He is (co-)author of more than 600 (Web of Science indexed) articles (Pubmed: 400) in international peer reviewed scientific journals. Dr. Guchelaar is coordinator of the EU funded Horizon 2020 project Ubiquitous Pharmacogenomics (www.upgx.eu) aimed at implementing pre-emptive pharmacogenomic testing in the EU.
From 2010-2016 he was a member of the Dutch National Central Committee on Research Involving Human Subjects, from 2003-2017, he was vice-chair of the Dutch Society for Clinical Pharmacology and Biopharmacy, and since 2016 he is member of the Dutch Medicines Evaluation Board. Since 2017, he is a member of Council for Medical Sciences of the Royal Dutch Academy of Science and since 2020 a member of the Academia Europea. Henk-Jan is founder of the new Master of Pharmacy, Leiden University Medical Center, University of Leiden.
Disclosure information not submitted.
Wednesday, March 16, 2022
12:30 PM – 1:30 PM ET
.png)